AzTrials
AzTrials

Photobiomodulation TherapyNCT06841120

Reversal of Anaesthesia with Diode Laser

A study testing Actual laser application in people with Photobiomodulation Therapy, run by Recep Tayyip Erdogan University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: After local anesthesia, which is frequently used in pediatric dentistry, long-term soft tissue numbness can cause various problems. The aim of this study was to evaluate the effectiveness of PBMT in reversing soft tissue anaesthesia in children following local anaesthesia administration. Read more about this study

Who is it for?
Ages 4 to 9 yearsHealthy volunteers can take part
Conditions the study is for
Photobiomodulation Therapy
What is being tested?
Actual laser application
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
18 Jan 2023to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 9 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • - Children whose parents signed the written informed consent form and who themselves gave assent,
  • Children with a Frankl behaviour rating scale score of 3 or 4,
  • Children aged between 4 and 9 years old who can understand soft tissue sensation and respond to it,
  • Children requiring treatment with local infiltration anaesthesia for multiple teeth in both the mandible and maxilla,
  • Children with no history of allergy to materials used for anaesthesia or sulphite,
  • Children who have not taken any analgesic medication at least 24 hours before treatment,
  • Children without any systemic conditions that would interfere with dental treatment under local anaesthesia.

Who cannot join

  • Occurrence of an error during anaesthesia injection resulting in insufficient anaesthesia for treatment,
  • Inability of the patient to provide clear assessments of response to soft tissue anaesthesia,
  • Presence of systemic conditions that would prevent anaesthesia administration or dental treatment,
  • Children requiring urgent dental treatment priority such as acute painful teeth.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Recep Tayyip Erdoğan University, Faculty of Dentistry

    Rize, Rize Province, 53100

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of Photobiomodulation Therapy with Diode Laser in Reversal of Maxillary and Mandibular Soft Tissue Local Anaesthesia in Paediatric Dentistry: Randomized Clinical Trial:a Randomized Clinical Trial

Background: After local anesthesia, which is frequently used in pediatric dentistry, long-term soft tissue numbness can cause various problems. The aim of this study was to evaluate the effectiveness of PBMT in reversing soft tissue anaesthesia in children following local anaesthesia administration.

Methods: In a split-mouth randomized study, 40 children aged 4 to 9 years, eligible to receive local infiltration injection on both maxillary (n=20) and mandibular (n=20) right and left sides, will included. Maxillary and mandibular quadrants will be randomly assigned to laser or sham laser groups. Normality will assessed using the Kolmogorov-Smirnov test. Categorical variables between laser and control groups will compared using the McNemar paired sample test. Significance will be set at p<0.05.

Being tested
Actual laser application, Sham laser application
Keywords
photobiomodulation therapy, diode laser, dental local anaesthesia, child

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Actual laser applicationDevice

    At approximately 45 minutes into the treatment session, subjects in the laser group received irradiation from a 4 W power, 810 nm diode laser (Fox; ARC Laser, GmbH, Nürnberg, Germany). The laser was operated in continuous mode, delivering 12-second shots per point using a therapy head with a point size of 0.38 cm². Each point received 6.3 J/cm² of laser energy, resulting in a total energy density of 37.8 J/cm² across 6 points.

  • Sham laser applicationDevice

    Sham laser was applied symbolically as a diffused closed laser (targeted beam) at the same distance and simultaneously. Evaluations after laser irradiation were conducted by a responsible specialist physician who was not involved in performing the treatment procedures.

Study groups in NCT06841120
Study groupRoleWhat they receive
Actual laser applicationExperimentalNot described
Receives: Device: Actual laser application
Sham laser was applied symbolicallySham comparatorNot described
Receives: Device: Sham laser application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anesthesia reversal time

    Until the first reversal of anesthesia, a palpation technique will be used to record every 10 minutes. With this technique, the presence of a sense of touch and tingling will be questioned. In order to obtain an objective answer, the child will be asked whether he/she knows what a tingling sensation is based on his/her previous experiences and will be told what and how this sensation is.

    Measured: up to 30 minutes after procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2025
  2. Study start18 Jan 2023
  3. Primary completion18 Jan 2024
  4. Study completion30 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06841120
Sponsor's protocol ID
RecepTayyipErdoganUniversity
Status last verified
Jan 2025
First submitted
21 Jan 2025
Last updated
24 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kurt A, Kibaroglu E, Yildirim H, Gumrukcu Z, Balaban E. Effect of 810-nm diode laser photobiomodulation on the reversal of maxillary and mandibular soft tissue local anaesthesia in children: a randomized split-mouth clinical trial. Sci Rep. 2026 Jul 13. doi: 10.1038/s41598-026-62428-z. Online ahead of print.

    PubMed 42443404

Questions about this trial

What is this clinical trial studying?

A study testing Actual laser application in people with Photobiomodulation Therapy, run by Recep Tayyip Erdogan University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anesthesia reversal time (time frame: up to 30 minutes after procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06841120, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in